Aminosyn Ii 8.5% W/ Electrolytes

   
Google
 
Web NewDrugInformation.com

Aminosyn Ii 8.5% W/ Electrolytes


Drug - Aminosyn Ii 8.5% W/ Electrolytes
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Amino Acids; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Dibasic; Sodium Chloride
Multiple ingredients are in alphabetical order.

Strength - 8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100ML
The potency of the active ingredient(s), Amino Acids; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Dibasic; Sodium Chloride. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Aminosyn Ii 8.5% W/ Electrolytes. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019437
The FDA assigned number to Aminosyn Ii 8.5% W/ Electrolytes. Format is nnnnnn.

Product Number - 005
The FDA assigned number to identify Aminosyn Ii 8.5% W/ Electrolytes. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 3, 1986
The date Aminosyn Ii 8.5% W/ Electrolytes was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Aminosyn Ii 8.5% W/ Electrolytes. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Aminosyn Ii 8.5% W/ Electrolytes is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Aminosyn Ii 8.5% W/ Electrolytes.

Aminosyn Ii 8.5% W/ Electrolytes


Aminosyn Ii 7% W/ Electrolytes 7%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection
Aminosyn Ii 8.5% W/ Electrolytes 8.5%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection
Aminosyn 3.5% M 3.5%;21mg/100ml;40mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Aminosyn 3.5% M In Plastic Container 3.5%;21mg/100ml;40mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Aminosyn 3.5% M In Plastic Container 3.5%;21mg/100ml;40mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Freamine Iii 3% W/ Electrolytes 3%;54mg/100ml;40mg/100ml;150mg/100ml;200mg/100ml;120mg/100ml Injectable; Injection
Aminosyn 3.5% M 3.5%;21mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection
Aminosyn Ii 3.5% M In Plastic Container 3.5%;32mg/100ml;128mg/100ml;222mg/100ml;49mg/100ml Injectable; Injection
Veinamine 8% 8%;61mg/100ml;211mg/100ml;56mg/100ml;388mg/100ml Injectable; Injection
Aminosyn Ii 10% W/ Electrolytes 10%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection

NewDrugInformation